Literature DB >> 6438237

A rat anti-mouse kappa chain specific monoclonal antibody, 187.1.10: purification, immunochemical properties and its utility as a general second-antibody reagent.

C F Ware, J L Reade, L C Der.   

Abstract

A rat IgG1 monoclonal antibody, produced by hybridoma 187.1.10, exhibits specificity for mouse immunoglobulins containing kappa light chains (Yelton et al., 1981). The 187.1.10 hybridoma cell line secreted upwards of 200 micrograms/ml of monoclonal antibody in tissue culture and the secreted product was purified in a single step by antigen-immunoadsorbent affinity chromatography. The homogeneity of the purified 187.1.10 protein was determined by isoelectrofocusing and SDS gel electrophoresis. Equilibrium binding analyses of the radioiodinated 187.1.10 antibody indicated a strong interaction with its antigen of KA = 2 X 10(9) l/mole. The 187.1.10 antibody did not readily bind to Staph. aureus protein A unless it was complexed with antigen. The binding of immune complexes of 187.1.10 to protein A was shown to be dependent on the Fc region of the antigen. The utility of the 187.1.10 monoclonal antibody as a general second antibody reagent for studying mouse immunoglobulins was demonstrated in a rapid solid phase immunoprecipitation assay to detect and analyze radioiodinated membrane proteins of a human cytotoxic T cell line.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438237     DOI: 10.1016/0022-1759(84)90371-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Production, characterization, and applications of monoclonal antibodies reactive with soybean nodule xanthine dehydrogenase.

Authors:  E W Triplett; C R Lending; D J Gumpf; C F Ware
Journal:  Plant Physiol       Date:  1986-04       Impact factor: 8.340

2.  Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes.

Authors:  R Holmdahl; M Andersson; A Tarkowski
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

3.  Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney.

Authors:  C Juhlin; R Holmdahl; H Johansson; J Rastad; G Akerström; L Klareskog
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis.

Authors:  R Holmdahl; L Jansson; M Andersson; E Larsson
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

5.  Purification and characterization of a pectin lyase produced by Pseudomonas fluorescens W51.

Authors:  A F Schlemmer; C F Ware; N T Keen
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

6.  Monoclonal antibodies raised against mid-gut carcinoid tumor cells.

Authors:  C Juhlin; V Papanicolaou; K Backlin; L Klareskog; E Wilander; G Akerström; K Oberg; J Rastad
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

7.  High antibody response to autologous type II collagen is restricted to H-2q.

Authors:  R Holmdahl; L Klareskog; M Andersson; C Hansen
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells.

Authors:  A Acevedo; M A del Pozo; A G Arroyo; P Sánchez-Mateos; R González-Amaro; F Sánchez-Madrid
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

9.  Role of receptor-binding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells.

Authors:  L C Eisenlohr; W Gerhard; C J Hackett
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins.

Authors:  S Chen; R Alon; R C Fuhlbrigge; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.